client logo
Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 228 days ago

NIHR BioResource: Sample holding

Dataset

Documentation

Description:
The NIHR Bioresource consists of several groups of participants: ~70k from the general population and blood donors (COMPARE, INTERVAL and STRIDES studies); ~19k with one of ~50 rare diseases (RD) including a ~5k pilot for GEL; ~30k with Inflammatory Bowel Disease (IBD) which include the members of Gut Reaction, the Health Data Research Hub for IBD; and ~20k with Anxiety or depression (GLAD study). It intends to extend recruitment in all areas, and to other rare and common disease groups, with a target of ~300k by 2022. The NIHR BioResource acquires samples at recruitment for each participant recruited. With the exception of the GLAD study, which posts saliva kits direct to participants’ homes, the preferred sample collection is 3 blood tubes – see https://bioresourcesupport.org.uk/live-samples/ - from which DNA can be extracted, and plasma and sera stored. In many clinics, the NIHR BioResource blood draw follows immediately the blood collection for routine healthcare purposes. In the case of children, less blood will be taken, down to 1mL. The Technical Metadata describes the standard used by RD-Connect, the EU-wide Rare Disease biobank consortium - https://samples.rd-connect.eu/menu/main/home. During 2020, this will be replaced by an API from the UK CRC Tissue Directory, as using this discovery tool is a condition of running a Research Tissue Bank in the UK.

Coverage

Spatial:
United Kingdom
Typical Age Range:
18-85
Follow Up:
1 - 10 Years

Provenance

Origin

Purposes:
Study
Sources:
LIMS
Collection Situations:
Other

Temporal

Accrual Periodicity:
Quarterly
Distribution Release Date:
31 March 2021
Start Date:
02 February 2005
Time Lag:
1-2 months

Accessibility

Access

Access Service:
Some de-identified data may be released to researchers in a platform-independent filetype (e.g. CSV). However, access to any data acquired via NHS Digital is subject to strict restrictions governing where data may be accessed and from which locale - access is currently via an experimental safe haven built in Microsoft Azure.
Delivery Lead Time:
Not applicable
Jurisdictions:
GB-GBN
Data Controller:
Cambridge University Hospitals NHS Foundation Trust (CUH)
Data Processor:
Data processors are NIHR BioResource staff, others with Letters of Access to CUH and approved members of staff at the data centre (AIMES, https://aimes.uk/)

Usage

Data Use Limitations:
Research use only
Data Use Requirements:
  • Institution-specific restrictions
  • Project-specific restrictions
  • Return to database or resource
  • Time limit on use
  • User-specific restriction
Resource Creators:
NIHR BioResource. Acknowledgement text: "We thank NIHR BioResource volunteers for their participation, and gratefully acknowledge NIHR BioResource centres, NHS Trusts and staff for their contribution. We thank the National Institute for Health Research, NHS Blood and Transplant, and Health Data Research UK as part of the Digital Innovation Hub Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care."

Format and Standards

Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
text/csv

Observations

Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Events
Sample tubes collected from participants
225265
COUNT
26 November 2020